1. Home
  2. WST vs THC Comparison

WST vs THC Comparison

Compare WST & THC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • THC
  • Stock Information
  • Founded
  • WST 1923
  • THC 1967
  • Country
  • WST United States
  • THC United States
  • Employees
  • WST N/A
  • THC N/A
  • Industry
  • WST Medical/Dental Instruments
  • THC Hospital/Nursing Management
  • Sector
  • WST Health Care
  • THC Health Care
  • Exchange
  • WST Nasdaq
  • THC Nasdaq
  • Market Cap
  • WST 20.1B
  • THC 17.7B
  • IPO Year
  • WST N/A
  • THC N/A
  • Fundamental
  • Price
  • WST $260.84
  • THC $192.98
  • Analyst Decision
  • WST Strong Buy
  • THC Buy
  • Analyst Count
  • WST 9
  • THC 19
  • Target Price
  • WST $354.50
  • THC $220.33
  • AVG Volume (30 Days)
  • WST 775.7K
  • THC 1.1M
  • Earning Date
  • WST 10-23-2025
  • THC 10-28-2025
  • Dividend Yield
  • WST 0.34%
  • THC N/A
  • EPS Growth
  • WST 0.17
  • THC N/A
  • EPS
  • WST 6.75
  • THC 14.57
  • Revenue
  • WST $3,017,900,000.00
  • THC $20,846,000,000.00
  • Revenue This Year
  • WST $6.97
  • THC $3.67
  • Revenue Next Year
  • WST $6.11
  • THC $4.52
  • P/E Ratio
  • WST $38.53
  • THC $13.24
  • Revenue Growth
  • WST 4.92
  • THC N/A
  • 52 Week Low
  • WST $187.43
  • THC $109.82
  • 52 Week High
  • WST $348.90
  • THC $217.43
  • Technical
  • Relative Strength Index (RSI)
  • WST 39.95
  • THC 41.95
  • Support Level
  • WST $258.93
  • THC $189.58
  • Resistance Level
  • WST $266.26
  • THC $202.44
  • Average True Range (ATR)
  • WST 9.07
  • THC 6.06
  • MACD
  • WST -3.18
  • THC -1.93
  • Stochastic Oscillator
  • WST 10.59
  • THC 13.70

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About THC Tenet Healthcare Corporation

Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.

Share on Social Networks: